Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation.

被引：1
|
作者：
An, Josiah
Yan, Melissa
Yu, Nanmeng
Chennamadhavuni, Adithya
Furqan, Muhammad
Kruser, Timothy
Sita, Timothy L.
Nguyen, Ryan
Feldman, Lawrence Eric
Pasquinelli, Mary
Hanna, Nasser H.
Abu Hejleh, Taher
机构：
[1] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
[2] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[3] Univ Iowa, Iowa City, IA USA
[4] Northwestern Mem Hosp, Chicago, IL 60611 USA
[5] Western Univ, Coll Osteopath Med Pacific, Pomona, CA USA
[6] Univ Illinois, Canc Ctr, Chicago, IL USA
[7] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9033
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation
    An, Josiah
    Yan, Melissa
    Yu, Nanmeng
    Chennamadhavuni, Adithya
    Furqan, Muhammad
    Mott, Sarah L.
    Loeffler, Bradley T.
    Kruser, Timothy
    Sita, Timothy L.
    Feldman, Lawrence
    Nguyen, Ryan
    Pasquinelli, Mary
    Hanna, Nasser H.
    Abu Hejleh, Taher
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (08) : 3608 - 3615
  • [2] Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer
    Rosellini, Pietro
    Amintas, Samuel
    Caumont, Charline
    Veillon, Remi
    Galland-Girodet, Sigolene
    Cuguilliere, Alain
    Nguyen, Laurent
    Domblides, Charlotte
    Gouverneur, Amandine
    Merlio, Jean-Philippe
    Bezin, Julien
    Girodet, Pierre-Olivier
    [J]. EUROPEAN JOURNAL OF CANCER, 2022, 172 : 85 - 95
  • [3] STK11 mutations in non-small cell lung cancer (NSCLC): descriptive analysis and prognostic significance
    Facchinetti, Francesco
    Bluthgen, Maria Virginia
    Clain, Gabrielle Tergemina
    Faivre, Laura
    Pignon, Jean-Pierre
    Planchard, David
    Soria, Jean-Charles
    Besse, Benjamin
    Lacroix, Ludovic
    [J]. CANCER RESEARCH, 2016, 76
  • [4] STK11/LKB1 mutation in non-small cell lung cancer: Prognostic or predictive?
    Rosellini, P.
    Girodet, P. O.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 50 - 51
  • [5] Role of STK11 in ALK-positive non-small cell lung cancer
    Zhou, Wen
    Yan, Lu-Da
    Yu, Zhi-Qiong
    Li, Na
    Yang, Yong-Hua
    Wang, Meng
    Chen, Yuan-Yuan
    Mao, Meng-Xia
    Peng, Xiao-Chun
    Cai, Jun
    [J]. ONCOLOGY LETTERS, 2022, 23 (06)
  • [6] Outcomes of Bimodality and Trimodality Therapy in Patients with Stage III Non-small Cell Lung Cancer (NSCLC)
    Hope, A. J.
    Coate, L. E.
    Massey, C.
    Sacher, A.
    Barrett, K.
    Keshavjee, S.
    Darling, G.
    Leighl, N. B.
    Bezjak, A.
    Shepherd, F. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S505 - S505
  • [7] Unraveling the Role of STK11/LKB1 in Non-small Cell Lung Cancer
    Sumbly, Vikram
    Landry, Ian
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [8] Impact of Concurrent STK11 Loss and c-MYC Amplification in Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Menon, S.
    Ellis, C.
    Poudel, S.
    Johnson, J.
    Szabo, A.
    George, B.
    Kelly, W. Kevin
    Grant, S.
    McPherson, J.
    Cristofanilli, M.
    Hoimes, C.
    Gutierrez, M.
    Doudement, J.
    Chan, L.
    Singal, G.
    Alexander, B.
    Miller, V.
    Sohal, D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S29 - S30
  • [9] Impact of STK11 and KRAS co-mutations on outcomes with immunotherapy in non-small cell lung cancer.
    Basher, Fahmin
    Saravia, Diana
    Fanfan, Dino
    Cotta, Jared Addison
    Lopes, Gilberto
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] RADIOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC)
    De Ruysscher, D.
    [J]. LUNG CANCER, 2009, 64 : S21 - S21
12345